Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
As AI continues to move beyond software and automation, its impact on genomics and gene editing is becoming increasingly tangible
-
Illumina, Inc. (ILMN) Misled Investors Regarding Insider's Personal Motives for Acquiring GRAIL
-
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Dec. 12, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Illumina, Inc. (“Illumina” or...
-
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Illumina, Inc. (“Illumina” or...
-
Illumina, Inc. (ILMN) Misled Investors Regarding Insider's Personal Motives for Acquiring GRAIL
-
Illumina, Inc. (ILMN) Misled Investors Regarding Insider's Personal Motives for Acquiring GRAIL
-
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Nov. 16, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Illumina, Inc. ("Illumina" or...
-
Illumina, Inc. (ILMN) Misled Investors Regarding Insider's Personal Motives for Acquiring GRAIL
-
LOS ANGELES, Nov. 10, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Illumina, Inc. (“Illumina” or the “Company”) (NASDAQ: ILMN) investors that a lawsuit filed on behalf of investors that...
-
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Oct. 31, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Illumina, Inc. ("Illumina"...